NonprofitsDana-Farber Cancer Institute

Medical Research

Dana-Farber Cancer Institute

BOSTON, MA

Total revenue

$3.5B

Total expenses

$3.4B

Net assets

$3.9B

Grants received

$1.0B

3,873 grants

EIN

042263040

Tax year

2023

Mission

See schedule o

Programs

2 programs

Research - see schedule o

Expenses: $802.6M

Community benefits - see schedule o

Expenses: $43.4MGrants: $7.6M

Financials

FY 2023

Revenue

Contributions & grants$779.2M
Program service revenue$2.6B
Investment income$5.7M
Other revenue$75.3M
Total revenue$3.5B

Expenses

Grants paid$7.6M
Salaries & benefits$1.1B
Fundraising$50.7M
Other expenses$2.3B
Total expenses$3.4B
Total assets$5.3B
Net assets$3.9B

People

50 listed

NameRoleCompensation

Laurie H Glimcher MD

Trustee, President & CEO

Board

$2.1M

44 hrs/wk

William Hahn MD PHD

COO & EVP

Board

$1.3M

49 hrs/wk

Michael L Reney

CFO & Assistant Treasurer

Board

$1.1M

46 hrs/wk

Jennifer Willcox ESQ

Asst Secretary & General Counsel

Board

$692K

50 hrs/wk

Eric Miller

Trustee

Board

1 hrs/wk

Eric Schlager

Trustee (END 1/29/24)

Board

1 hrs/wk

Esta Stecher

Trustee

Board

1 hrs/wk

Fatima Penrose

Trustee

Board

1 hrs/wk

Frank Laukien

Trustee

Board

1 hrs/wk

Frederica Williams

Trustee

Board

1 hrs/wk

Gary Prado

Trustee

Board

1 hrs/wk

Harvey Berger MD

Trustee

Board

1 hrs/wk

Hise Gibson

Trustee

Board

1 hrs/wk

James McCann

Trustee

Board

1 hrs/wk

Jane Brock-Wilson

Trustee

Board

1 hrs/wk

Jane Jamieson

Trustee

Board

1 hrs/wk

Jennifer Perini

Trustee

Board

1 hrs/wk

Jessica Knez Dulac

Trustee

Board

1 hrs/wk

Jill Greenthal

Trustee

Board

1 hrs/wk

Jodi Walker

Trustee

Board

1 hrs/wk

Jose Aguerrevere

Trustee

Board

1 hrs/wk

Karen Daley PHD MPH RN FANN

Trustee

Board

1 hrs/wk

Karen Hale

Trustee (END 4/5/24)

Board

1 hrs/wk

Karen Linde Packman

Trustee

Board

1 hrs/wk

Kate Gulliver

Trustee

Board

1 hrs/wk

Kevin DaSilva

Trustee

Board

1 hrs/wk

Kimberly Sherman Stamler

Trustee

Board

1 hrs/wk

Laura Sen

Trustee

Board

1 hrs/wk

Levi Garraway

Trustee

Board

1 hrs/wk

Lisa Ferraro

Trustee

Board

1 hrs/wk

Louise Svanberg

Trustee

Board

1 hrs/wk

Mary Ann Tocio

Trustee (END 1/29/24)

Board

1 hrs/wk

Meg Reynolds

Trustee

Board

1 hrs/wk

Michael Eisenson

Trustee

Board

1 hrs/wk

Michael Trotsky

Trustee

Board

1 hrs/wk

Elizabeth Liebow

Former Key Employee

Staff

$1.2M

0

Craig A Bunnell MD MPH MBA

Chief Medical Officer

Staff

$964K

50 hrs/wk

Melany Duval

SVP & Chief Philanthropy Officer

Staff

$938K

50 hrs/wk

Robert Soiffer MD

Chair Executive Committee for Clinical Programs

Staff

$839K

50 hrs/wk

Scott Armstrong MD PHD

Chair of Pediatric Oncology

Staff

$820K

50 hrs/wk

Michael Constantine MD

Milford Med Dir-Hematology/Oncology

Staff

$801K

50 hrs/wk

Bruce Johnson MD

Sr. Advisor to President & CEO

Staff

$749K

49 hrs/wk

Jeffrey Meyerhardt MD MPH

Chief Clinical Research Officer

Staff

$720K

50 hrs/wk

Maria Megdal

SVP Chief Administrative Officer

Staff

$670K

50 hrs/wk

Kevin Haigis PHD

Chief Scientific Officer

Staff

$668K

50 hrs/wk

Barrett J Rollins MD PHD

Sr. Advisor to President & CEO

Staff

$547K

50 hrs/wk

John O Chesley ESQ

Counsel

Staff

$456K

0

Wendy Gettleman

VP of Facilities Management & Real Estate

Staff

$390K

50 hrs/wk

Sylvia A Bartel RPh MHP

SR. VP of Pharmacy & CPO

Staff

$360K

50 hrs/wk

Benjamin Ebert MD PhD

CHAIR OF MEDICAL ONCOLOGY

Staff

$209K

49 hrs/wk

Independent contractors

BRIGHAM AND WOMEN'S HOSPITAL

MEDICAL SERVICES

$218.5M

CARDINAL HEALTH

MEDICAL SERVICES

$51.4M

South Shore Hospital

Medical Services

$30.3M

Advanced Accelerator Applications USA Inc

Radiotherapy

$30.1M

Cardinal Health 110 Inc

Medical Services

$26.3M

Grants received

Showing 200 of 3,873

FromAmountPurposeYear
$75M
Cancer Research
2024
$12M
ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES
2024
$5.4M
SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
2024
$3.2M
Support/Research
2024
$2.5M
SUPPORT FOR CLINICAL STUDIES AND TO ADVANCE DISCOVERIES AND NEW TECHNOLOGIES IN CANCER RESEARCH
2024
$2.1M
ATLAS PROJECT & TEAM SCIENCE
2024
$2M
CENTER FOR THERAPEUTIC DISCOVERY
2024
$1.9M
PEDIATRIC CANCER RESEARCH
2024
$1.2M
MEDICAL / PUBLIC SERVICES
2024
$1.2M
to support a leading cancer treatment and research center dedicated to providing expert patient care and developing new therapies for cancer patients.
2024
$1.2M
to support a leading cancer treatment and research center dedicated to providing expert patient care and developing new therapies for cancer patients.
2024
$1.1M
CANCER RESEARCH
2024
$1M
UNRESTRICTED GRANT TO SUPPORT THE ORGANIZATION'S EXEMPT PURPOSE.
2024
$1M
PROGRAM SUPPORT
2024
$1M
SITE INVESTMENT GRANT, PREVENTION
2024
$1M
YOUNG INVESTIGATOR AWARD, CAREER DEVELOPMENT AWARD, ADVANCED CLINICAL RESEARCH AWARD
2024
$1M
GENERAL PURPOSES
2024
$975K
1 TEAM SCIENCE AWARD, 1 NEXT STEPS: MELANOMA BIOMARKER DEVELOPMENT AWARD
2024
$914K
Sched I Supplemental
2024
$843K
Raise awareness and support research and treatment of childhood cancer.
2024
$750K
PATHWAYS OF ENERGY EXPENDITURE AND NEW THERAPEUTICS FOR METABOLIC DISEASES
2024
$671K
GENERAL SUPPORT
2024
$621K
Health, Medicine & Science
2024
$607K
AMPVAX: A DISRUPTIVE PERSONAL CANCER VACCINE
2024
$602K
RESEARCH GRANT
2024
$514K
HOSPITALS
2024
$500K
EDUCATIONAL
2024
$500K
TO ADVANCE BCOR FUSION POSITIVE SARCOMA RESEARCH
2024
$500K
UNRESTRICTED GIFT FOR ITS GENERAL PURPOSES
2024
$500K
TO SUPPORT A RESEARCH PROJECT
2024
$475K
CANCER RESEARCH
2024
$460K
TOWARDS THE CENTER FOR NEURO-ONCOLOGY FOR GLIOBLASTOMA RESEARCH
2024
$450K
The objective of this project is to identify aberrantly expressed age-related drivers of cancer in individuals with inherited cancer syndromes related to BRCA mutations. This project will help develop preventive measures such as vaccines targeting cancer-initiating progenitor cells.
2024
$444K
UNRESTRICTED GENERAL SUPPORT
2024
$425K
PEDIATRIC CANCER STUDY
2024
$423K
GENERAL PROGRAM
2024
$423K
GENERAL PROGRAM
2024
$414K
IMPROVING TREATMENT OF ERBB2 LUNG CANCERS (IDENTIFYING SYNERGISTIC COMBINATION VIA CRISPR SCREEN)
2024
$369K
GENERAL SUPPORT
2024
$336K
FOR RECIPIENT'S EXEMPT PURPOSE
2024
$333K
FUNCTIONALIZING THE ASD VARIOME - CORE
2024
$307K
CLINICAL TRIAL AND CORRELATIVE RESEARCH GRANTS
2024
$300K
CLL research grant
2024
$300K
TO SUPPORT DR. MARINAC'S RESEARCH
2024
$300K
ONCOLOGY/ CHILD HUNGER
2024
$300K
Research
2024
$274K
MEDICAL / PUBLIC SERVICES
2024
$258K
SUPPORT CHARITABLE PROGRAMS
2024
$250K
TO SUPPORT THE FUND FOR EARLY DETECTION AND DR. MARINAC'S WORK
2024
$250K
TO SUPPORT MELANOMA CANCER RESEARCH
2024
$250K
MEDICAL RESEARCH
2024
$232K
EARLY DETECTION OF OVARIAN CANCER
2024
$201K
PRE-CLINICAL TESTING OF CDK4/6 INHIBITORS AS A THERAPEUTIC STRATEGY IN ALZHEIMER'S DISEASE USING AD TAUOPATHY MOUSE MODEL
2024
$200K
UNRESTRICTED PROGRAM GRANT
2024
$200K
DR. MARINAC'S RESEARCH
2024
$180K
GENERAL USE
2024
$170K
SCREENING & DIAGNOSTICS,PATIENT NAV
2024
$155K
Cancer Research
2024
$152K
RESEARCH CONTRACTS
2024
$150K
FOR DONEE'S EXEMPT PURPOSE
2024
$150K
NEW INVESTIGATOR AWARDS
2024
$150K
Conduct research in CLL
2024
$148K
RESEARCH GRANT(S)
2024
$146K
Research
2024
$138K
DR. ALLISON O'NEILL FOR PEDIATRIC HEPATOBLASTOMA RESEARCH
2024
$135K
TO FUND CHARITABLE MISSION OF CHARITABLE ORGANIZATION - ADULT PATIENT ASSITANCE, CHILDREN'S BLOOD CANCER, PATIENT CARE FUND, RESEARCH FUND
2024
$125K
DR. BIRGIT KNOECHEL RESEARCH ON PEDIATRIC CANCER OUTCOMES
2024
$125K
TO SUPPORT CUTTING-EDGE RESEARCH TO FIND TREATMENTS AND CURES FOR ALL FORMS OF CANCER.
2024
$125K
DR. KIRA BONA FOR RESEARCH ON PEDIATRIC CANCER OUTCOMES IN LOW-INCOME FAMILIES
2024
$115K
CANCER RESEARCH
2024
$113K
HL - HEALTHY LIVES (PRIMARY)
2024
$106K
HEALTH, GENERAL
2024
$106K
CANCER RESEARCH
2024
$100K
TRAVEL GRANT
2024
$100K
General support
2024
$100K
CHARITABLE CONTRIBUTION
2024
$100K
ONCOLOGY RESEARCH
2024
$100K
Biobank for Innovative Cancer Research and Care
2024
$100K
DANA-FARBER CANCER INSTITUTE TO SUPPORT LUNG CANCER RESEARCH AND PATIENT CARE.
2024
$100K
TO AID IN THE EXEMPT PURPOSE OF THE ORGANIZATION
2024
$100K
RESEARCH
2024
$100K
DR. BRIAN CROMPTON HTT PROFILING CIRECULATING DNA
2024
$100K
HEALTH CARE ACCESS FOR UNDERSERVED INDIVIDUALS & COMMUNITIES
2024
$90K
TO PROVIDE FINANCIAL SUPPORT FOR THE MISSION OF THE ORGANIZATION.
2024
$90K
MYELOMA RESEARCH
2024
$88K
GENERAL
2024
$84K
TO FURTHER THE ORGANIZATION'S EXEMPT PURPOSE
2024
$80K
COMMUNITY SERVICE
2024
$80K
MONEY GRANTED TO FIGHT AGAINST CANCER
2024
$75K
SERVICES FOR PEDIATRIC CANCER PATIENTS & FAMILIES
2024
$75K
THE CHARITABLE PURPOSE OF THIS SUBGRANT IS TO UNDERSTAND THE POTENTIAL OF AND CHALLENGES TO USING INTERNET DATA TO FACILITATE TIMELY, ACCURATE DIAGNOSIS AND TREATMENT.
2024
$70K
CHARITABLE CONTRIBUTION
2024
$69K
FELLOWSHIP RESEARCH
2024
$65K
PARTICIPATION IN THE PERFORMANCE OF THE RESEARCH PROJECT WITH THE AIM OF DEVELOPING NEW THERAPEUTIC STRATEGIES TO TACKLE GLIOBLASTOMAS, SPECIFICALLY TO IDENTIFY VULNARABILITIES IN THERAPY RESISTANCE AND DEVELOPING NEW TARGETED STRATEGIES FOR GLIOBLASTOMA
2024
$62K
Technical Assistance
2024
$60K
CANCER RESEARCH
2024
$56K
HOSPITALS, SPECIALTY HOSPITALS & COMMUNITY CLINICS
2024
$53K
BREAST CANCER RESEARCH
2024
$51K
PROGRAM SUPPORT
2024
$51K
PROGRAM SUPPORT
2024
$50K
REMITTANCE OF DONOR
2024
$50K
METASTATIC BREAST CANCER RESEARCH
2024
$50K
To map the transcriptional and protein changes induced by lactate and identify the mechanisms that cause NK suppression, on both NK and tumor cells, using high-throughput and unbiased approaches.
2024
$50K
PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA
2024
$50K
EXEMPT PURPOSE
2024
$50K
RESEARCH
2024
$50K
STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR EARLY TREATMENT OF OLIGOMETASTATIC ADENOID CYSTIC CARCINOMA: THE SOLAR TRIAL
2024
$50K
CANCER RESEARCH
2024
$50K
General Support
2024
$50K
TO SUPPORT MEDICAL RESEARCH
2024
$50K
UNRESTRICTED GENERAL SUPPORT
2024
$50K
FOR THE MATCHING GRANT TO SUPPORT THE FY2024 CLAUDIA ADAMS BARR FELLOW, SHRESTHA GHOSH, PHD, AS A NEWLY APPOINTED SCIENTIST IN BASIC CANCER RESEARCH WHO HAS NOT PREVIOUSLY RECEIVED THE CLAUDIA ADAMS BARR PROGRAM RESEARCH FUNDING.
2024
$50K
To map the transcriptional and protein changes induced by lactate and identify the mechanisms that cause NK suppression, on both NK and tumor cells, using high-throughput and unbiased approaches.
2024
$48K
INSTITUTIONAL SUPPORT FOR CANCER RESEARCH
2024
$47K
UNRESTRICTED GENERAL
2024
$45K
Dr. Reinherz - Harnessing T Cells for Immune-oncology.
2024
$40K
GENERAL SUPPORT
2024
$40K
CANCER CARE AND RESEARCHCANCER CARE AND RESEARCH
2024
$40K
DIRECTOR RECOMMENDED - GENERAL OPERATING SUPPORT
2024
$36K
Capacity Building
2024
$36K
DONOR DESIGNATION/GRANT
2024
$35K
Dr. Janne's research on therapeutic targeting of drug induced persister cells
2024
$35K
Dr. David Barbie Research sensitizing small cell lung cancer to immune checkpoint blockade by restoring neoantigen displayEducation
2024
$34K
PROGRAM SUPPORT
2024
$33K
PEDIATRIC CANCER RES
2024
$33K
GENERAL OPERATING
2024
$31K
GENERAL SUPPORT
2024
$30K
UNRESTRICTED GENERAL SUPPORT
2024
$30K
DANA-FARBER CANCER INSTITUTE NURSE PRACTITIONER FELLOWSHIP IN PALLIATIVE CARE
2024
$30K
TO FURTHER DONEE'S EXEMPT PURPOSE
2024
$30K
Support Sick and Hungry Kids
2024
$30K
For general support, Jimmy Fund, research, designated distribution
2024
$29K
UNRESTRICTED GENERAL
2024
$29K
TO SUPPORT PSYCHEDELIC RESEARCH AT DANA-FARBER CANCER INSTITUTE.
2024
$28K
CANCER RESEARCH
2024
$26K
Capacity Building
2024
$25K
GENERAL
2024
$25K
GENERAL CHARITABLE OPERATIONS
2024
$25K
MEDICAL RESEARCH
2024
$25K
In support of Dana-Farber Cancer Institute, which provides expert, compassionate, and equitable care to children, adults, and their families, while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases.
2024
$25K
GENERAL OPERATING SUPPORT
2024
$25K
FOR PROGRAM SUPPORT.
2024
$25K
GENERAL SUPPORT
2024
$25K
CHARITABLE SUPPORT
2024
$22K
GENERAL SUPPORT
2024
$21K
CANCER TREATMENT AND RESEARCH
2024
$20K
to provide expert, compassionate, and equitable care to children, adults, and their families while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases
2024
$20K
General support
2024
$20K
RESEARCH - SAJNI FUND FOR PEDIATRIC BRAIN CANCER
2024
$20K
GENERAL OPERATIONS
2024
$20K
FURTHER TAX EXEMPT PURPOSE
2024
$20K
PROGRAM/PROJECT SUPPORT
2024
$19K
PEDIATRIC CANCER RES
2024
$18K
GENERAL SUPPORT; PROGRAM/PROJECT SUPPORT
2024
$18K
DONATIONS TO COLLEGES, UNIVERSITIES AND OTHER ORGANIZATIONS UNDER "MATCHING GIFTS PROGRAM."
2024
$17K
GENERAL SUPPORT
2024
$16K
Research
2024
$16K
Program Support
2024
$15K
SCIENTIFIC RESEARCH
2024
$15K
CANCER RESEARCH
2024
$15K
HEALTH
2024
$15K
Support of the Dana-Farber Cancer Institute annual Discovery Ball.
2024
$15K
GENERAL SUPPORT
2024

Funded by

$1.0B from 1,384 funders · 3,873 grants · 2016–2024

Pan-Massachusetts Challenge Inc

$216M · 3 grants · 2022–2024

Fidelity Investments Charitable Gift Fund

$110.8M · 8 grants · 2017–2023

Paula And Rodger Riney Foundation

$46.5M · 4 grants · 2020–2024

President and Fellows of Harvard College

$30.7M · 6 grants · 2017–2023

The Leukemia & Lymphoma Societyinc

$26.0M · 31 grants · 2017–2023

The Broad Institute Inc

$22.1M · 8 grants · 2017–2023

Parker Institute For Cancer Immunotherapy

$17.0M · 4 grants · 2019–2024

Details

EIN042263040
NTEE codeH300
Subsection03
Ruling date1962-04
Formed1951
Employees9211
Volunteers500
DANA-FARBER CANCER INSTITUTE — Mission, Financials & Grants Received | Grantivo